Resistance Training in Intradialysis Patients
DIAPRE
Phase 1 RCT of Progressive Resistance Training on Small Solute Clearance, Functional Capacity and Quality of Life in Intradialysis Patients
1 other identifier
interventional
46
1 country
1
Brief Summary
Dialysis patients usually have peripheral muscle weakness due to metabolic disturbances (increased protein catabolism) and fatigue. This muscle weakness may decrease functional capacity and quality of life. It also serves to increase cardiovascular risk factors in these end stage renal disease patients. Peripheral muscle strength training shall combat physical inactivity during dialysis. In the investigators trial, the investigators hypothesis that peripheral muscle training might regulate protein catabolic rate,renal functions, cardiovascular risk factors, improve functional capacity and quality of life in endstage renal disease patients undergoing dialysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Oct 2010
Longer than P75 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2010
CompletedFirst Posted
Study publicly available on registry
February 9, 2010
CompletedStudy Start
First participant enrolled
October 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2016
CompletedSeptember 10, 2013
September 1, 2013
4.5 years
February 4, 2010
September 8, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Serum and Urea biochemistry - electrolytes (Na, K+), serum albumin, inflammatory markers, urea kinetics, protein catabolic rate
Bimonthly
Secondary Outcomes (7)
Maximal Oxygen Consumption (VO2 max) and Heart Rate Recovery through Queens College step test
Once Monthly
Fat levels by skin fold measurements
Once monthly
Handgrip strength by dynamometer
Once monthly
Six minute walk test distance
Once monthly
Quality of life (KDQOL - SF questionnaire)
Once monthly
- +2 more secondary outcomes
Study Arms (2)
Prgressive Resistance Exercise Training
EXPERIMENTALProgressive Resistance Exercise Training thrice a week for 12 weeks. For first two weeks, 60% of 5 repetition maximum, progressing at 5% of 5 repetition maximum each week reaching upto 110% of 5 Repetition maximum at the end of 12 weeks
Unstructured Resistance Exercise
ACTIVE COMPARATORUnstructured Resistance Exercise thrice a week for 12 weeks. For 12 weeks, 20% 5 repetition maximum (which will not induce training effect and any physiological responses)and free range of motion exercises with no progression.
Interventions
Progressive Resistance Exercise Training thrice a week for 12 weeks. For first two weeks, 60% of 5 repetition maximum, progressing at 5% of 5 repetition maximum each week reaching upto 110% of 5 Repetition maximum at the end of 12 weeks
Unstructured Resistance Exercise 30 minutes a day, thrice a week for 12 weeks. For 12 weeks, 20% 5 repetition maximum (which will not induce training effect and any physiological responses)and free range of motion exercises with no progression.
Eligibility Criteria
You may qualify if:
- Must have end stage renal disease (diagnosed and the stage graded by nephrologist or the intensivist concerned) for more than 6 months and dialysis for at least 3 months (the impact of exercise training can be easily assessed)
- Must be between the ages of 30 - 60 years of age/ both genders.
- Must be able to understand the purpose of exercise testing and resistance training.
You may not qualify if:
- Those with acute nephritic syndrome and hematuria \< 2 months.
- Those with profound anemia and blood transfusion \< 2 months
- Those underwent renal transplantation \< 6 months.
- Those receiving/ received cytotoxic drugs - amiloride, azathioprine/ aspirin (antiplatelets)\< 2 months
- Those with coagulation disorders or under anticoagulants \< 4 months.
- Those underwent recent cardiac surgeries and with recent unstable cardiac failures
- Those with recent cerebrovascular accidents \< 6 months
- Those have recent urinary tract infections, Renal and bladder carcinomas \< 2 months
- Those with absolute contraindications for resistance exercise training (as per American College of Sports Medicine.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Central Referral Hospital, SMIMS
Gangtok, Sikkim, 737102, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Baskaran Chandrasekaran, MPT
Lecturer / Consultant cardiopulmonary Physiotherapist
- STUDY CHAIR
Bidhan C Sharma, MPT
Assistant Professor/ Consultant Physiotherapist
- STUDY CHAIR
Manish Goon, BPT
Clinical Physiotherapist
- STUDY CHAIR
Nikita Joshi, MPT
Head of Department/ Associate Professor
- STUDY CHAIR
Arpan Battacharia, MD
Dialysis Unit Incharge
- STUDY DIRECTOR
Bidita Kandelwal, MD
Head of Medicine Department
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Physiotherapist
Study Record Dates
First Submitted
February 4, 2010
First Posted
February 9, 2010
Study Start
October 1, 2010
Primary Completion
April 1, 2015
Study Completion
August 1, 2016
Last Updated
September 10, 2013
Record last verified: 2013-09